Interpharma Brain Health: Addressing Stress & Mood Swings in Thailand
- Bangkok, Thailand - February 29, 2024 - Interpharma Public Company Limited is expanding into the preventative health market with a new "Brain Health" product line, responding to increasing...
- Interpharma reports a significant increase in stress, anxiety, and burnout levels among the Thai population, driven by demanding work schedules, academic pressures, and broader socio-economic factors.
- Data from the Department of Mental Health, Ministry of Public Health indicates a steady rise in reported cases of anxiety and depression.
“`html
Interpharma Launches Brain Health Line Amid Rising Stress & Anxiety in Thailand
Table of Contents
Bangkok, Thailand - – Interpharma Public Company Limited is expanding into the preventative health market with a new “Brain Health” product line, responding to increasing rates of stress, anxiety, and burnout among Thai workers and students.
The Growing Mental Health Crisis in Thailand
Interpharma reports a significant increase in stress, anxiety, and burnout levels among the Thai population, driven by demanding work schedules, academic pressures, and broader socio-economic factors. This trend aligns with global observations, but is notably acute in Thailand’s rapidly evolving surroundings.
Data from the Department of Mental Health, Ministry of Public Health indicates a steady rise in reported cases of anxiety and depression. In 2022, approximately 1.8 million Thais were estimated to be living with depression, a 13% increase from 2017. Moreover, a 2023 survey by Mahidol University’s Ramathibodi Hospital found that over 60% of office workers reported experiencing moderate to high levels of stress.
The Gut-Brain Axis: A New Frontier in Mental Wellbeing
Interpharma’s strategy centers on the increasingly recognized connection between gut health and brain function – the “Gut-brain Axis.” This bidirectional dialog system highlights the crucial role of the microbiome in regulating mood, sleep, and the body’s stress response.
Research published in Nature Reviews Gastroenterology & Hepatology demonstrates that imbalances in gut microbiota can contribute to anxiety, depression, and cognitive impairment. The Brain Health line aims to address these imbalances through targeted nutritional support.
Introducing the Brain Health Innovation Line
The new product line focuses on restoring balance and supporting optimal brain function. Key products include:
- PROBAC MOOD – Psychobiotic: Contains specific probiotic strains clinically studied for their positive impact on mood, anxiety reduction, and memory enhancement. These strains, such as Lactobacillus helveticus and Bifidobacterium longum, have shown promise in modulating the HPA axis (hypothalamic-pituitary-adrenal axis), a key regulator of the stress response.
- Magnesium plus B complex - Relax & Recovery: Offers a highly absorbable form of magnesium combined with B vitamins to alleviate nervous system tension and promote relaxation. Magnesium deficiency is linked to increased anxiety and sleep disturbances.
- Somnix: (Details not provided in source, requires further information)
- Lisa DHA: (Details not provided in source, requires further information)
Sleep Deprivation and its Impact
Dr. Trinawat Thanitnithiphan,CEO of Interpharma,emphasizes that preventative health extends beyond treating illness. He highlights the critical importance of maintaining bodily balance, particularly the gut-brain connection, to address the growing issues of mood, stress, and sleep quality in Thailand.
The company specifically addresses the widespread problem of sleep deprivation, common among office workers, shift workers, and students. Chronic sleep loss disrupts the gut microbiome, increasing susceptibility to mood swings, anxiety, and cognitive fatigue.According to the Sleep Foundation, adults who consistently get less than